Henry Letocha

898 total citations
35 papers, 641 citations indexed

About

Henry Letocha is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Henry Letocha has authored 35 papers receiving a total of 641 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 14 papers in Surgery. Recurrent topics in Henry Letocha's work include Colorectal Cancer Treatments and Studies (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Cancer Treatment and Pharmacology (5 papers). Henry Letocha is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Cancer Treatment and Pharmacology (5 papers). Henry Letocha collaborates with scholars based in Sweden, Austria and Germany. Henry Letocha's co-authors include Kenneth Smedh, Peter Strang, C. Lindemalm, Leif Bergkvist, Per‐Uno Malmström, Maziar Nikberg, Abbas Chabok, J. Shetye, Laurent Mineur and Meinolf Karthaus and has published in prestigious journals such as Journal of Clinical Oncology, Pain and British Journal of Cancer.

In The Last Decade

Henry Letocha

33 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry Letocha Sweden 15 356 243 231 82 75 35 641
Imran Bhatti United Kingdom 10 486 1.4× 145 0.6× 275 1.2× 39 0.5× 127 1.7× 34 804
Kenji Sugano Japan 12 474 1.3× 136 0.6× 205 0.9× 43 0.5× 91 1.2× 22 702
Lesley Meyer United Kingdom 7 525 1.5× 469 1.9× 263 1.1× 153 1.9× 70 0.9× 9 1.2k
Mustafa Oktay Tarhan Türkiye 18 612 1.7× 228 0.9× 108 0.5× 45 0.5× 117 1.6× 63 867
Kelsey C. Stoltzfus United States 12 360 1.0× 224 0.9× 136 0.6× 95 1.2× 86 1.1× 17 745
Joanne Lewis United Kingdom 10 130 0.4× 149 0.6× 200 0.9× 35 0.4× 60 0.8× 35 574
B. Johansson Sweden 18 214 0.6× 127 0.5× 400 1.7× 85 1.0× 68 0.9× 43 1.0k
Anthony Turpin France 16 472 1.3× 242 1.0× 193 0.8× 73 0.9× 74 1.0× 109 777
Yaşar Yıldız Türkiye 18 381 1.1× 138 0.6× 124 0.5× 23 0.3× 128 1.7× 67 798
Emer O’Connell Ireland 13 254 0.7× 92 0.4× 154 0.7× 31 0.4× 66 0.9× 35 527

Countries citing papers authored by Henry Letocha

Since Specialization
Citations

This map shows the geographic impact of Henry Letocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Letocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Letocha more than expected).

Fields of papers citing papers by Henry Letocha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry Letocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Letocha. The network helps show where Henry Letocha may publish in the future.

Co-authorship network of co-authors of Henry Letocha

This figure shows the co-authorship network connecting the top 25 collaborators of Henry Letocha. A scholar is included among the top collaborators of Henry Letocha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry Letocha. Henry Letocha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nikberg, Maziar, et al.. (2015). Circumferential Resection Margin as a Prognostic Marker in the Modern Multidisciplinary Management of Rectal Cancer. Diseases of the Colon & Rectum. 58(3). 275–282. 30 indexed citations
2.
Rosenblad, Andreas, et al.. (2012). Long-term follow-up of a randomized study of support group intervention in women with primary breast cancer. Journal of Psychosomatic Research. 74(4). 346–353. 31 indexed citations
3.
Lindemalm, C., et al.. (2012). A randomized controlled trial of a support group intervention on the quality of life and fatigue in women after primary treatment for early breast cancer. Supportive Care in Cancer. 20(12). 3325–3334. 31 indexed citations
4.
Thaler, Josef, Meinolf Karthaus, Laurent Mineur, et al.. (2012). Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study. BMC Cancer. 12(1). 438–438. 31 indexed citations
5.
6.
Lindemalm, C., et al.. (2011). A randomised controlled trial of support group intervention after breast cancer treatment: Results on anxiety and depression. Acta Oncologica. 51(2). 198–207. 34 indexed citations
7.
Köhne, Claus‐Henning, Ralf‐Dieter Hofheinz, Laurent Mineur, et al.. (2011). First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer. Journal of Cancer Research and Clinical Oncology. 138(1). 65–72. 60 indexed citations
8.
Karthaus, Meinolf, Ralf‐Dieter Hofheinz, Laurent Mineur, et al.. (2009). Epidermal growth factor receptor (EGFR) inhibitor–related skin toxicity: Review of interim data from a phase II study (20060314) of panitumumab (pmab) with FOLFIRI in the first-line treatment of metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 27(15_suppl). e20634–e20634. 6 indexed citations
9.
Berglund, Åke, Per Byström, Birgitta Johansson, et al.. (2009). An explorative randomised phase II study of sequential chemotherapy in advanced upper gastrointestinal cancer. Medical Oncology. 27(1). 65–72. 4 indexed citations
10.
Greil, Richard, Henry Letocha, Érick Gamelin, et al.. (2009). Updated analysis of a phase II study (20060314) of panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 27(15_suppl). 4085–4085. 4 indexed citations
11.
12.
Beshara, Soheir, et al.. (1997). Anemia associated with advanced prostatic adenocarcinoma: Effects of recombinant human erythropoietin. The Prostate. 31(3). 153–160. 20 indexed citations
13.
Letocha, Henry, et al.. (1996). Deoxythymidine kinase in the staging of prostatic adenocarcinoma. The Prostate. 29(1). 15–19. 8 indexed citations
14.
Edgren, M, Jan‐Erik Westlin, Henry Letocha, et al.. (1996). Estramustine-Binding Protein (EMBP) in Renal Cell Carcinoma Immunohistochemistry, Immunoscintigraphy and in Vitro Estramustine Effects. Acta Oncologica. 35(4). 483–488. 3 indexed citations
15.
Lennernäs, Bo, et al.. (1995). External Beam Radiotherapy Of Localized Prostatic Adenocarcinoma: Evaluation Of Conformal Therapy, Field Number And Target Margins. Acta Oncologica. 34(7). 953–958. 19 indexed citations
16.
Westlin, Jan‐Erik, Henry Letocha, Åke Jakobson, et al.. (1995). Rapid, reproducible pain relief with [131I]iodine-meta-iodobenzylguanidine in a boy with disseminated neuroblastoma. Pain. 60(1). 111–114. 6 indexed citations
17.
18.
Letocha, Henry, Per‐Uno Malmström, Christer Busch, & Sten Nilsson. (1994). The Efficacy of Preoperative Systemic Chemotherapy in the Local Control of Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder. Acta Oncologica. 33(5). 519–522. 2 indexed citations
19.
Letocha, Henry, et al.. (1993). Immunotargeting with Monoclonal Cytokeratin 8 Antibodies of Human Urothelial Cancer Transplanted to Nude Mice. Acta Oncologica. 32(7-8). 793–800. 5 indexed citations
20.
Nilsson, Sten, Sven Påhlman, Henrik Arnberg, Henry Letocha, & Jan‐Erik Westlin. (1993). Characterization and Uptake of Radiolabelled Meta-Iodobenzylguanidine (Mibg) in a Human Neuroblastoma Heterotransplant Model in Athymic Rats. Acta Oncologica. 32(7-8). 887–891. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Imran Bhatti Breakdown of academic impact, for papers by Kenji Sugano Breakdown of academic impact, for papers by Lesley Meyer Breakdown of academic impact, for papers by Mustafa Oktay Tarhan Breakdown of academic impact, for papers by Kelsey C. Stoltzfus Breakdown of academic impact, for papers by Joanne Lewis Breakdown of academic impact, for papers by B. Johansson Breakdown of academic impact, for papers by Anthony Turpin Breakdown of academic impact, for papers by Yaşar Yıldız Breakdown of academic impact, for papers by Emer O’Connell
Rankless by CCL
2026